Call us : USA : 1-631-466-5530; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Vaccine Blog Creative Biolabs Vaccine Blog

Menu

Skip to content
  • Vaccine Research
  • Popular Vaccine
  • Vaccine News

Vaccine Development Services

Creative Biolabs effectively supports the vaccine industry with a full range of vaccine design and production services and related products.

Know More

Vaccine Technologies

Creative Biolabs focuses on all kinds of Vaccine Technologies that include Vaccine Target Validation, Monoclonal Antibody Vaccines, Cell Based Vaccines and more.

Know More

RSV Vaccine R&D: Advancing in a Rocky Path with Hope

December 10, 2020Popular Vaccine, Vaccine NewsRespiratory Syncytial Virus, ResVax, RSV vaccinebiovaccine

Respiratory syncytial virus (RSV) is the most common pathogen of viral pneumonia in children, which occurs mostly in newborns and infants less than 6 months old, as well as in immunodeficiency patientsRead More…

Analysis of Vaccine Reviews-Episode II

November 30, 2020Vaccine Newsvaccine challenges, vaccine sciencebiovaccine

1. Type of vaccine Advances in virology, molecular biology, and immunology have created many alternatives to traditional vaccines. Modern vaccines include nucleic acid (mRNA, DNA) vaccines, viral vector vaccines, virus-like particles andRead More…

Analysis of Vaccine Reviews-Episode I

November 30, 2020Vaccine Newsvaccine antigens, vaccine history, vaccine reviewbiovaccine

Vaccines can greatly prevent infectious diseases. Between 1924 and 2010, 103 million childhood diseases were prevented in the United States through vaccination alone. In particular, smallpox was eliminated by vaccines in 1980,Read More…

Science: Human Antibody Response to Novel Coronavirus is Beneficial to the Development of Vaccine

October 13, 2020Vaccine Newscoronaviruses, human antibody response, SARS-CoV-2biovaccine

A tool designed to detect the history of viral infection from a drop of blood has been upgraded in the COVID-19 era. VirScan is a technique that determines which of more thanRead More…

Nature: Mouse-adapted SARS-CoV-2 model lays the foundation for testing drugs and vaccines

September 2, 2020Vaccine Researchmice model, SARS-CoV-2, vaccine preclinical testbiovaccine

In a new study, researchers from the University of North Carolina at Chapel Hill and other research institutions have developed a new COVID-19 mouse model that reproduces many of the features ofRead More…

Melanoma Combination Therapy: mRNA Cancer Vaccine and Immune Checkpoint Inhibition

August 21, 2020Vaccine News, Vaccine Researchcancer vaccine, DC mRNA vaccine, mRNA Vaccine, Personalized cancer vaccinebiovaccine

MRNA is a kind of nucleic acid molecule that carries genetic information. MRNA vaccine transduces genetic information into the body and produce corresponding antigens, which can induce neutralizing antibodies and stimulate TRead More…

New Research: novel coronavirus’s evolution clues

July 12, 2020Popular Vaccine, Vaccine Newscoronavirus, RaTG13, SARS-CoV-2, spike glycoproteins, vaccine designbiovaccine

According to a new virological research paper published in Nature-structure and Molecular Biology, a professional academic journal of Springer Nature, through a comparative study on the structure of the novel coronavirus (SARS-CoV-2)Read More…

Russia has developed intranasal novel coronavirus vaccine

June 4, 2020Popular Vaccine, Vaccine NewsCOVID-19, novel coronavirus vaccine, SARS-CoV-2biovaccine

Mark Shotov, director of the “Vector” National Virology and Biotechnology Research Center of the Russian Federation’s Consumer Rights Protection and Public Welfare Supervision Agency, said the center had developed an intranasal novelRead More…

Lancet Infect Dis: MERS coronavirus vaccine is expected to treat MERS

May 8, 2020Popular Vaccine, Vaccine ResearchMERS, MVA, MVA-MERS-S, SARS-CoV-2, the Middle East Respiratory Syndrome coronavirusbiovaccine

Recently, researchers have found that a Middle East respiratory syndrome coronavirus vaccine has shown efficacy in human trials, which may help to develop a vaccine against the new virus. Professor Marylyn Addo,Read More…

mRNA vaccine of SARS-CoV-2 is under development

April 7, 2020Popular Vaccine, Vaccine NewsCOVID-19, mRNA Vaccine, vaccine developmentbiovaccine

Sanofi Pasteur recently announced the development of a new mRNA vaccine for COVID-19. In February, Sanofi Pasteur announced that it would begin to develop a recombinant protein candidate vaccine for COVID-19. DavidRead More…

Posts navigation

  • 1
  • 2
  • 3
  • Next »

Categories

  • Popular Vaccine
  • Vaccine News
  • Vaccine Research

Recent Posts

  • RSV Vaccine R&D: Advancing in a Rocky Path with Hope
  • Analysis of Vaccine Reviews-Episode II
  • Analysis of Vaccine Reviews-Episode I
  • Science: Human Antibody Response to Novel Coronavirus is Beneficial to the Development of Vaccine
  • Nature: Mouse-adapted SARS-CoV-2 model lays the foundation for testing drugs and vaccines

Archives

  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018

Contact Us

USA:
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-466-5530
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
Europe:
Tel: 44-207-097-1828
Copyright © Creative Biolabs Vaccine Blog
Powered by WordPress , Designed and Developed by templatesnext
MENU
  • Vaccine Research
  • Popular Vaccine
  • Vaccine News